Success Metrics

Clinical Success Rate

50.0%

Based on 2 completed trials

Completion Rate

50%(2/4)

Active Trials

0(0%)

Results Posted

0%(0 trials)

Terminated

2(40%)

Phase Distribution

Ph not_applicable

20%

Ph phase_4

40%

Ph phase_2

40%

Phase Distribution

Early Stage

Mid Stage

Late Stage

Phase Distribution5 total trials

Phase 2Efficacy & side effects

2(40.0%)

Phase 4Post-market surveillance

2(40.0%)

N/ANon-phased studies

1(20.0%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

trials recruiting

Total Trials

all time

Status Distribution

Completed(2)

Terminated(2)

Other(1)

Detailed Status

Completed2

Terminated2

unknown1

Development Timeline

Analytics

Development Status

Total Trials

Active

Success Rate

50.0%

Most Advanced

Phase 4

Trials by Phase

Phase 22 (40.0%)

Phase 42 (40.0%)

N/A1 (20.0%)

Trials by Status

completed240%

unknown120%

terminated240%

Recent Activity

0 active trials

Showing 5 of 5

terminatedphase_2

The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery

NCT03183479

Clinical Trials (5)

Showing 5 of 5 trials

NCT05091684Phase 2

Administration of Fibrinogen Concentrate for Refractory Bleeding

Terminated

NCT05391412Phase 4

Effect of Prophylactic Fibrinogen Concentrate In Scoliosis Surgery

Unknown

NCT04434001Phase 2

ZEPLAST- PED: ZEro_PLASma Trial in Small Infants Undergoing Cardiac Surgery

Terminated

NCT03784794Not Applicable

Patient Blood Management for Massive Obstetric Hemorrhage

Completed

NCT03183479Phase 4

The Effects of Fibrinogen Concentrate Infusion on Blood Loss and Allogeneic Blood Conservation in Scoliosis Surgery

Completed

All 5 trials loaded

Drug Details

Intervention Type: DRUG
Total Trials: 5